Cyclopharm
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WACyclopharm Limited (CYC) is involved in manufacturing and selling of medical equipment and radiopharmaceuticals, including associated research and development. Its products are Technegas and Molecular Imaging, which are offered to nuclear medicine departments in hospitals and clinics in Europe, Canada and Asia Pacific.
Contact Details
Unit 4, 1 The Cr, KINGSGROVE NSW 2208
02 9541 0411
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1259th | Cyclopharm | -29% | 4% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Cyclopharm | $31.7m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
 | NEW ROLE: John Wigglesworth, Non-Executive Director | 25 Jul 2024 |
| NEW ROLE: Gregory King, Non-Executive Director | 25 Jul 2024 |
| NEW ROLE: Kevin Barrow, Non-Executive Director | 25 Jul 2024 |
| NEW ROLE: Dianne Angus, Non-Executive Director | 01 Dec 2023 |
| NEW ROLE: Mathew Farag, Chief Operating Officer | 24 Nov 2020 |
| NEW ROLE: David J Heaney, Non-Executive Director, Non-Executive Chairman | 03 Nov 2020 |
| NEW ROLE: Tom A McDonald, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: James S McBrayer, Chief Executive Officer, Managing Director, Company Secretary | 03 Nov 2020 |
